Clinical Trials Directory

Trials / Completed

CompletedNCT03151798

The Liver Health Study for Patients with NAFLD

Nutrient Overload, Insulin Resistance, and Hepatic Mitochondrial Dysfunction

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
336 (actual)
Sponsor
University of Missouri-Columbia · Academic / Other
Sex
All
Age
22 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The study will investigate whether the level of fat stored in the liver is related to the liver's ability to burn fat.

Detailed description

The study has two phases. In Phase I, liver samples from patients undergoing bariatric surgery or a diagnostic liver biopsy will be tested for the ability to burn fatty acids. In Phase II, patients with nonalcoholic fatty liver disease will participate in either a nine-month lifestyle treatment program or undergo standard care. The goal is to determine how weight loss and exercise improve liver health. Inpatient comprehensive metabolic tests are performed before and after the nine-months.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPhase II: Lifestyle treatmentSubjects will undergo energy restriction and exercise training over a 9 month period.
BEHAVIORALPhase II: Control treatmentSubjects will receive dietary advice and receive information on a stretching program.
OTHERPhase I: Observational studiesThe liver samples from patients undergoing bariatric surgery or a diagnostic liver biopsy will undergo in vitro assays to determine the capacity of the tissue to burn fat

Timeline

Start date
2017-08-09
Primary completion
2022-03-03
Completion
2023-04-29
First posted
2017-05-12
Last updated
2024-12-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03151798. Inclusion in this directory is not an endorsement.

The Liver Health Study for Patients with NAFLD (NCT03151798) · Clinical Trials Directory